Verified stock metrics
Scribe Therapeutics Key Stock Metrics
Direct answer
Scribe Therapeutics has 5 verified key metrics available.
Market capitalization, valuation, profitability and growth facts share the same observation time.
Only reported values are shown. Missing values are not estimated.
Market data checked October 5, 2026.
Get free Scribe Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Market capitalization
- $317.86M
- Dividend yield
- 0%
- 52-week price range
- $16.49 to $39.60
- Revenue growth
- -60.8%
- Profit margin
- -97%